Hosted on MSN1mon
FDA Approves Treosulfan as Part of AML/MDS Conditioning RegimenThe FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation in patients ages 1 year and older with acute myeloid ...
A new research paper titled "ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells" has been published in Oncotarget. ABT199 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback